Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07622407 · ClinicalTrials.gov registry record · NA

Maximizing Quality of Life After Cancer Through Rehabilitation

A NA study, sponsored by VA Office of Research and Development.

Not yet
Registry status
NA
Development phase
74
Enrollment target

NCT07622407: Clinical Trial NA study, sponsored by VA Office of Research and Development.

NCT07622407 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07622407, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.

NOT YET RECRUITING
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

Treatment for head and neck cancer (HNC) often includes cisplatin chemotherapy and radiation. This treatment causes hearing loss and trouble swallowing in 70% of patients. If untreated, these symptoms increase stress and lower quality of life for survivors. Veterans with HNC usually get help for swallowing. However, damage to the hearing and balance systems-known as ototoxicity-is often missed or only addressed when it becomes very severe. To fill this gap, the investigators plan a clinical trial at two VA sites. The investigators compare the usual swallowing therapy alone to a new, more comprehensive program. This new program includes: 1. the standard swallowing therapy, 2. proactive management to protect hearing and balance or manage problems that can't be prevented, and 3. other rehabilitation services based on a tele-oncology nurse's assessment. The hearing and balance intervention features quick screening tests and validated questionnaires to identify early signs of damage. These are given during cancer or radiation treatment visits to maximize convenience for the patient. Audiologists review these results remotely using tele-health technology. The investigators will also use new tools to predict and spot hearing problems that are personalized for each patient. The audiologist works closely with the patient and the care team to arrange further help if needed. The tele-oncology nurse checks for other rehabilitation needs using a screening tool validated in Veterans, shares this information with the team, and advises patients about recommended care. The investigators expect the results to show that managing hearing loss with swallowing therapy while improving care coordination for rehabilitation reduces survivors' stress and improves well-being compared to swallowing therapy alone.

Interventions

  • OTHER TIMELY REHAB

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2027-03-01
Est. Completion 2030-06-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT07622407

The ClinicalTrials.gov registry entry for NCT07622407 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which TIMELY REHAB is the first listed.

NCT07622407 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07622407 about?

NCT07622407 is a clinical study titled "Maximizing Quality of Life After Cancer Through Rehabilitation". Treatment for head and neck cancer (HNC) often includes cisplatin chemotherapy and radiation. This treatment causes hearing loss and trouble swallowing in 70% of patients. If untreated, these symptoms increase stress and lower quality of life for survivors. Veterans with HNC usually get help for swa...

What is the current status of trial NCT07622407?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2027-03-01. Estimated completion is 2030-06-30.

What interventions are being tested in trial NCT07622407?

The interventions under investigation include: TIMELY REHAB (OTHER).

Who is sponsoring clinical trial NCT07622407?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.